Al Rahbani, G.K.; Woopen, C.; Dunsche, M.; Proschmann, U.; Ziemssen, T.; Akgün, K.
SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma. Vaccines 2024, 12, 684.
https://doi.org/10.3390/vaccines12060684
AMA Style
Al Rahbani GK, Woopen C, Dunsche M, Proschmann U, Ziemssen T, Akgün K.
SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma. Vaccines. 2024; 12(6):684.
https://doi.org/10.3390/vaccines12060684
Chicago/Turabian Style
Al Rahbani, Georges Katoul, Christina Woopen, Marie Dunsche, Undine Proschmann, Tjalf Ziemssen, and Katja Akgün.
2024. "SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma" Vaccines 12, no. 6: 684.
https://doi.org/10.3390/vaccines12060684
APA Style
Al Rahbani, G. K., Woopen, C., Dunsche, M., Proschmann, U., Ziemssen, T., & Akgün, K.
(2024). SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma. Vaccines, 12(6), 684.
https://doi.org/10.3390/vaccines12060684
